Showing results (61-70 of 518) with videos related to

Sort By:
Pageof 52
European Respiratory Review : an Official Journal of the European Respiratory Society|December 2, 2015
Second-line combination therapies in nonsmall cell lung cancer without known driver mutationsMaria-Virginia Bluthgen, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2026
Non-Small Cell Lung Cancer (NSCLC) in Vulnerable and Special Populations: Towards Personalized CareClaudia Parisi, Andrea De Giglio, Marco Banini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung CancerEmma Pailler, Vincent Faugeroux, Marianne Oulhen, et al.
Cancer Treatment Reviews|July 20, 2025
De-escalation strategies with targeted therapies in non-small cell lung cancerMartina Bortolot, Jordi Remon, Paolo Bironzo, et al.
Drugs|January 9, 2020
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung CancerNoemí Reguart, Elba Marin, Jordi Remon, et al.
Oncotargets and Therapy|August 9, 2020
Update on Targeted Therapies for Advanced Non-Small Cell Lung Cancer: Durvalumab in ContextSneha Gullapalli, Jordi Remon, Lizza E L Hendriks, et al.
Presse Medicale (Paris, France : 1983)|September 4, 2013
Thymic tumours: an updateValentina Polo, Nicolas Girard, Benjamin Besse
European Respiratory Review : an Official Journal of the European Respiratory Society|September 2, 2014
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of responseJessica Menis, Baktiar Hasan, Benjamin Besse
The European Respiratory Journal|May 2, 2015
Therapeutic management of ALK+ nonsmall cell lung cancer patientsBoris Duchemann, Luc Friboulet, Benjamin Besse
Pageof 52